炎症性肠病进展期结直肠肿瘤预后因素的系统综述与Meta分析
该系统综述与Meta分析纳入164项研究,汇总分析31个潜在预后因素,发现13个进展期结直肠肿瘤危险因素和5个保护因素,证据强度分为强、中、弱三级,为基于风险分层的IBD结直肠癌监测奠定基础。
要点
- 广泛病变是唯一证据强度为「强」的危险因素
- 低级别上皮内瘤变、狭窄、PSC、炎症后息肉、CRC家族史等为中等证据危险因素
- 结肠镜监测、5-ASA、硫嘌呤和吸烟为中等证据保护因素
核心结论
- 该Meta分析在IBD患者中识别出13个进展期结直肠肿瘤危险因素和5个保护因素,证据强度基于单变量和/或多变量汇总分析。
研究设计与样本
- 系统综述与Meta分析,按MOOSE指南进行文献检索,纳入164项研究,对31个潜在预后因素进行汇总分析。
- 采用Quality in Prognostic Studies工具评估偏倚风险,分别对OR和HR、不同研究设计及单变量或多变量数据建立随机效应模型。
主要发现
- 单变量分析中,广泛病变的证据强度为「强」,低级别上皮内瘤变、狭窄、原发性硬化性胆管炎、炎症后息肉、CRC家族史及溃疡性结肠炎vs克罗恩病的证据强度为「中」。
- 任何上皮内瘤变、结肠段切除、非整倍体、男性及年龄的证据强度为「弱」;组织学炎症在多变量分析中被识别为危险因素(弱证据)。
- 单变量分析中,结肠镜监测、5-氨基水杨酸、硫嘌呤及吸烟作为保护因素的证据强度为「中」;多变量分析为他汀使用提供了弱证据。
关键数值与推荐
- 证据强度分类依据效应量估计、异质性和偏倚风险,分为「弱」「中」「强」三级。
临床怎么用
- 研究结果可为IBD患者基于CRC风险分层的改进监测策略提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC). We performed a systematic review and meta-analysis to identify all prognostic factors for advanced colorectal neoplasia (aCRN, high-grade dysplasia, or CRC) in patients with IBD. METHODS: A systematic literature search was conducted according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines. Risk of bias was assessed using the Quality in Prognostic Studies tool. Random-effects models were created separately for odds and hazard ratios, different study designs, and univariable or multivariable data. The evidence for all prognostic factors was categorized as "weak", "moderate", or "strong", based on estimate of effect sizes, heterogeneity, and risk of bias. RESULTS: A total of 164 studies were included, allowing pooled analysis of 31 potential prognostic factors. In the univariable analysis, the evidence for extensive disease was classified as strong while evidence for low-grade dysplasia, strictures, primary sclerosing cholangitis, post-inflammatory polyps, family history of CRC, and ulcerative colitis versus Crohn's disease was considered moderate. Evidence for any dysplasia, colon segment resection, aneuploidy, male sex, and age was classified as weak. In addition, histologic inflammation was identified as a risk factor in multivariable analysis (weak evidence). The evidence for the protective factors colonoscopic surveillance, 5-Aminosalicylic Acid, thiopurines, and smoking was moderate in univariable analysis. Multivariable analysis provided weak evidence for statin use. CONCLUSIONS: In this systematic review and meta-analysis, we identified 13 risk factors and 5 protective factors for aCRN in IBD patients, based on univariable and/or multivariable pooled analyses. These findings might lay the groundwork for an improved CRC risk stratification-based surveillance in IBD.
引用
- Wijnands AM, de Jong ME, Lutgens MWMD, et al. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology. 2020. PMID: 33385426. doi:10.1053/j.gastro.2020.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。